glp1 tirzepatide side effects long term What are the long-term complications of taking tirzepatide (a glucagon-like peptide-1 (GLP-1) receptor agonist) in patients with a history of type 2 diabetes or obesity? Weighing up the Risks: GI

Additionally, the safety of these drugs is put into perspective with that of other drugs currently approved for the treatment of PLWO

For instance, taking tirzepatide in the evening may allow any mild side effects to subside overnight

Mounjaro: Targets both GLP-1 and GIP receptors, offering a dual-action mechanism that has shown greater effectiveness in controlling blood sugar and supporting weight loss

This makes it mechanistically distinct from single GLP-1 pathway products and relevant to research on combined metabolic signaling

Improved Blood Sugar Levels: Enhances insulin secretion and reduces blood glucose levels, beneficial for those with type 2 diabetes

The decision belongs with a licensed prescriber who weighs your goals, health, tolerability, and budget